Search research articles
Contact Us
Filters
Showing results (951-960 of 1,013) with videos related to
Page
of 102
Sort By:
Bone Marrow Transplantation
|
July 19, 2011
Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay
G Dufort, S Pisano, A Incoronato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
M L Rothenberg, J R Eckardt, J G Kuhn, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K Legault, H Schunemann, C Hillis, et al.
Journal of Psychiatric Research
|
March 10, 2022
Obsessive-compulsive disorder during the COVID-19 pandemic
M Van Ameringen, B Patterson, J Turna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
M L Rothenberg, J G Kuhn, L J Schaaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer
A Poveda, J M Del Campo, I Ray-Coquard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors
R L Drengler, J G Kuhn, L J Schaaf, et al.
Brain Stimulation
|
February 25, 2021
Accelerated neuromodulation therapy for Obsessive-Compulsive Disorder
Nolan R Williams, Keith D Sudheimer, Eleanor J Cole, et al.
CNS Spectrums
|
May 28, 2019
Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)
Bernardo Dell'Osso, Matteo Vismara, Beatrice Benatti, et al.
Neurology
|
March 7, 2008
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
J E Landers, A L Leclerc, L Shi, et al.
Page
of 102
Search research articles
Search
Showing results (951-960 of 1,013) with videos related to
Sort By:
Page
of 102
Bone Marrow Transplantation
|
July 19, 2011
Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay
G Dufort, S Pisano, A Incoronato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
M L Rothenberg, J R Eckardt, J G Kuhn, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K Legault, H Schunemann, C Hillis, et al.
Journal of Psychiatric Research
|
March 10, 2022
Obsessive-compulsive disorder during the COVID-19 pandemic
M Van Ameringen, B Patterson, J Turna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2002
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
M L Rothenberg, J G Kuhn, L J Schaaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer
A Poveda, J M Del Campo, I Ray-Coquard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors
R L Drengler, J G Kuhn, L J Schaaf, et al.
Brain Stimulation
|
February 25, 2021
Accelerated neuromodulation therapy for Obsessive-Compulsive Disorder
Nolan R Williams, Keith D Sudheimer, Eleanor J Cole, et al.
CNS Spectrums
|
May 28, 2019
Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)
Bernardo Dell'Osso, Matteo Vismara, Beatrice Benatti, et al.
Neurology
|
March 7, 2008
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
J E Landers, A L Leclerc, L Shi, et al.
Page
of 102